Younger age of onset of gout in Taiwan

Rheumatology

Volumn 42, Issue 1, 2003, Pages 166-170

  Yu, K H ^a   Luo, S F ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chinese; Clinical features; Community; Gout; Medical centre; Tophi

Indexed keywords

ANTIGOUT AGENT; DIURETIC AGENT; URICOSURIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FAMILY HISTORY; FEMALE; GOUT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PRIVATE HOSPITAL; RACE DIFFERENCE; SEX RATIO; TAIWAN; UROLITHIASIS;

ADULT; AGE OF ONSET; AMBULATORY CARE FACILITIES; FEMALE; GOUT; HUMANS; INCIDENCE; JOINTS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIVATE SECTOR; RETROSPECTIVE STUDIES; RHEUMATOLOGY; SEX DISTRIBUTION; TAIWAN; URINARY CALCULI;

EID: 0037243782     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg035     Document Type: Article

References (32)

1. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia; a long-term population study. Am J Med 1967;42:27-37.
2. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
3. O'Sullivan JB. Gout in a New England town. A prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972; 31:166-9.
4. Currie WJC. Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979;38:101-6.
5. Akizuki S. A population study of hyperuricemia and gout in Japan: Analysis of sex, age and occupational differences in thirty-four thousand living in Nagano Prefecture. Ryumachi 1982;22:201-8.
6. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: A population study of urban, suburban, rural differences. J Rheumatol 1994;21:302-6.
7. Kelley WN, Wortmann RL. Gout and hyperuricemia. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: W.B. Saunders, 1997:1313-51.
8. Michael AB, Levinson DJ. Clinical gout and the pathogenesis of hyperuricemia. In: Koopman WJ, ed. Arthritis and allied conditions. Baltimore: Williams & Wilkins, 1997:2041-72.
9. Yu GH, Chen JY, Wu Y-JJ, Ho HH, Luo SF. Retrospective analysis of 822 gout patients. J Rheumatol ROC 1993;10:20-9.
10. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20:895-900.
11. Chen YC, Cheng TT, Wu CH, Liang HM, Chu CK. Issues on gout and hyperuricemia. Chang Gung Yi Hsuen 1999; 20:9-21.
12. Yu GH, Chen JY, Wu Y-JJ, Ho HH, Luo SF. Clinical features of 1226 gout patients [abstract]. J Intern Med ROC 1993;4:226.
13. Nishioka N, Mikanagi K. Clinical features of 4,000 gouty subjects in Japan. Adv Exp Med Biol 1980; 122A:47-54.
14. Yu TF. Diversity of clinical features in gouty arthritis. Semin Arthritis Rheum 1984;13:360-8.
15. O'Duffy JD, Hunder GG, Kelly PJ. Decreasing prevalence of tophaceous gout. Mayo Clin Proc 1975;50:227-8.
16. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6.
17. Kuo TP. Gout in the tropical Taiwan. J Formosan Med Assoc 1964;63:415-26.
18. Sheffield FJ. Rheumatoid arthritis and gout: a study in Taiwan. J Formosan Med Assoc 1963;62:435-9.
19. Schumacher HR. Rheumatology and rheumatic disease in the Republic of China [editorial]. J Rheumatol 1982; 9:161-71.
20. Chen CY. Clinical study of gouty arthritis. J Formos Med Assoc 1963;62:62-70.
21. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000;27:1045-50.
22. Mikkelsen WM, Dodge HJ, Valkenburg HA, Himes S. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Tecumseh, Michigan, 1959-1960. Am J Med 1965;39:242-51.
23. Duff IF, Mikkelsen WM, Dodge HJ, Himes DS. Comparison of uric acid levels in some Oriental and Caucasian groups unselected as to gout or hyperuricemia. Arthritis Rheum 1968;11:184-90.
24. Chou P, Soong LN, Lin HY. Community-based epidemiological study on hyperuricemia in Pu-Li, Taiwan. J Formos Med Assoc 1993;92:597-602.
25. Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000;27:1501-5.
26. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan's Aborigines. J Rheumatol 1997;24:1364-9.
27. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998; 37:258-62.
28. Lin JL, Lim PS. Elevated lead burden in Chinese patients without occupational lead exposure. Miner Electrolyte Metab 1992;18:1-5.
29. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001; 28:1640-6.
30. Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 1973;16:431-45.
31. Yu TF. Milestones in the treatment of gout. Am J Med 1974;56:676-85.
32. Hench PS. The diagnosis of gout and gouty arthritis. J Lab Clin Med 1936;220:48-55.